Epstein Secrets

nnual Meeting EFTA_R1_02011009 EFTA02686135 Dariusz Jacek Krawiec John Krenicki Nicholas D. Kristof Patrick Kron Fred Krupp Andre Kudelski Michael Kuhndt Peter Kukielski Timur Kulibayev Ellen Kullman Manu Kumar Howard Kunreuther Rolf Kuntz Vera Kurochkina Kiyoshi Kurokawa Tapio Kuula Nabil R.

cutive Officer Business Editor Secretary-General Chief Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Developme

enry R. Kravis Dariusz Jacek Krawiec John Krenicki Jr Nicholas D. Kristof Neelie Kroes Patrick Kron Fred Krupp Andre Kudelski Aleksey Kudrin Michael Kuhndt Peter Kukielski Timur Kulibayev Ellen Kullman Manu Kumar Howard Kunreuther Rolf Kuntz Vera Kurochkina Haruhiko Kuroda Vice-President, Europe

Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Publi

enry R. Kravis Dariusz Jacek Krawiec John Krenicki Jr Nicholas D. Kristof Neelie Kroes Patrick Kron Fred Krupp Andre Kudelski Aleksey Kudrin Michael Kuhndt Peter Kukielski Timur Kulibayev Ellen Kullman Manu Kumar Howard Kunreuther Rolf Kuntz Vera Kurochkina Haruhiko Kuroda Vice-President, Europe

Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Publi